Sanara MedTech Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -36.28 | -100% |
| P/S |
|
4.88 | 33.75 | -85.56% |
|
|
| P/BV |
|
7.11 | 4.82 | 47.5% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-81.07 | -22.17 | 265.66% |
|
|
| Ev/S |
|
4.98 | 22.56 | -77.94% |
|
|
| Ev/FCF |
|
-92.14 | 68.75 | -234.02% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-6.14 | 4.98 | -223.36% | -21.66 | -71.66% |
| ROE |
|
-9.6 | 9.61 | -199.86% |
|
|
| ROA |
|
-5.83 | 0.3443 | -1792.12% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-6.62 | -25.17 | -73.7% |
|
|
| ROCE |
|
-17.19 | 15.35 | -211.99% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2.52 | -3.68 | -31.44% | -9.19 | -72.58% |
| Nеt Debt/Ebitda |
|
-1.67 | -3.44 | -51.54% |
|
|
| Debt/Ratio |
|
0.1361 | 0.1985 | -31.42% |
|
|
| Debt/Equity |
|
7.18 | 1.51 | 375.1% |
|
|
| Debt/Net Income |
|
-2.34 | 10.32 | -122.63% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
9.81 | 43.56 | -77.49% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
450.76 | -56.89 | -892.34% | ||
| Growth impulse Ebitda in 5 years |
|
-88.44 | -54.68 | 61.74% | ||
| Growth impulse Net Income in 5 years |
|
48.39 | -58.33 | -182.96% | ||
| Growth impulse FCF in 5 years |
|
-9.98 | -49.48 | -79.83% | ||
| Growth impulse EPS in 5 years |
|
-36.66 | -32.41 | 13.11% |
IP Score
2.74/10
